Skip to main content
Clinical Trials/NL-OMON56740
NL-OMON56740
Recruiting
Not Applicable

Sequential diagnostics of pulmonary fungal infections - SIGNALS

Radboud Universitair Medisch Centrum0 sites120 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
invasive fungal infection
Sponsor
Radboud Universitair Medisch Centrum
Enrollment
120
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • Age 18 yrs and older • Inclusion within 1 day before start of cytoreductive
  • treatment or remission induction chemotherapy for acute myeloid leukemia (AML)
  • or myelodysplastic syndrome (MDS) OR for myeloablative conditioning of
  • allogeneic stem cell transplantation (HSCT) including FLAMSA conditioning •
  • Expected absolute neutrophil count of \<0\.5 x109 for at least 10 days • No
  • previous or current history of proven or probable IMD • No current diagnosis of
  • pneumonia • No current respiratory distress or ventilation support ( low flow
  • oxygen is permitted ie by nasal canula) • Patients must be able to be
  • transferred to the radiology department for scanning • Female subjects with
  • childbearing potential must have a negative serum (or urine) pregnancy test

Exclusion Criteria

  • Pregnant female subjects
  • Current or previous history of primary or metastatic lung malignancy
  • Treatment for pulmonary fungal infection in preceding 3 months
  • Inflammatory bowel disease or any inflammatory bowel condition

Outcomes

Primary Outcomes

Not specified

Similar Trials